These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38084140)
1. Inhibition of hepatocellular carcinoma growth Li S; Cai X; Chen L; Lin M; Zhu Z; Xiao H; Nie P; Chen Q; Yang X PeerJ; 2023; 11():e16593. PubMed ID: 38084140 [TBL] [Abstract][Full Text] [Related]
2. Berberine activates PPARδ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma. Shou JW; Shaw PC Phytomedicine; 2023 Jul; 115():154842. PubMed ID: 37148713 [TBL] [Abstract][Full Text] [Related]
3. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11. Liu Z; Chen JY; Zhong Y; Xie L; Li JS Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526 [TBL] [Abstract][Full Text] [Related]
4. Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Wang K; Zhang C; Bao J; Jia X; Liang Y; Wang X; Chen M; Su H; Li P; Wan JB; He C Sci Rep; 2016 Jun; 6():26064. PubMed ID: 27263652 [TBL] [Abstract][Full Text] [Related]
6. A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis. Zhao JA; Nie W; Dong L; Liu W; Wei W J Gastroenterol Hepatol; 2021 Oct; 36(10):2967-2977. PubMed ID: 33982329 [TBL] [Abstract][Full Text] [Related]
7. Berberine enhances the radiosensitivity of hepatoma cells by Nrf2 pathway. You X; Cao X; Lin Y Front Biosci (Landmark Ed); 2019 Jun; 24(7):1190-1202. PubMed ID: 31136975 [TBL] [Abstract][Full Text] [Related]
8. Curcumin restrains hepatocellular carcinoma progression depending on the regulation of the circ_0078710/miR-378b/PRIM2 axis. Chen Q; Guo H; Zong Y; Zhao X J Recept Signal Transduct Res; 2022 Jun; 42(3):313-324. PubMed ID: 34139933 [TBL] [Abstract][Full Text] [Related]
9. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells. Abdallah FM; Helmy MW; Katary MA; Ghoneim AI Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1399-1410. PubMed ID: 30155693 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of MiR-34 Family and DNA Methyltransferases 1, 3A, 3B Gene Expression Levels in Hepatocellular Carcinoma Following Treatment with Dendrosomal Nanocurcumin. Chamani F; Sadeghizadeh M; Masoumi M; Babashah S Asian Pac J Cancer Prev; 2016; 17(S3):219-24. PubMed ID: 27165229 [TBL] [Abstract][Full Text] [Related]
11. LINC01605 regulates proliferation, migration and invasion of colorectal cancer cells via targeting miR-3960/SOX11. Hu SS; Fu L; Han SY; Li XL; Zhang LD Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1322-1329. PubMed ID: 33629302 [TBL] [Abstract][Full Text] [Related]
12. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379 [TBL] [Abstract][Full Text] [Related]
13. Berberine inhibits the development of endometrial cancer through circ_ZNF608/miR-377-3p/COX2 axis. Liang H; Liu Y; Fu L; Li L; Gong N Autoimmunity; 2022 Nov; 55(7):485-495. PubMed ID: 35876160 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration. Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122 [TBL] [Abstract][Full Text] [Related]
15. Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR‑429. Gu Y; Zhou Z Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846796 [TBL] [Abstract][Full Text] [Related]
16. Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation. Song L; Luo Y; Wang X; Almutairi MM; Pan H; Li W; Liu Y; Wang Q; Hong M Mol Med Rep; 2019 Nov; 20(5):4654-4664. PubMed ID: 31545468 [TBL] [Abstract][Full Text] [Related]
17. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis. Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588 [TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits proliferation of hepatocellular carcinoma cells through down regulation of DJ-1. Han L; Wang Y; Sun S Cancer Biomark; 2020; 29(1):1-8. PubMed ID: 32417759 [TBL] [Abstract][Full Text] [Related]
19. E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription. Hao F; Wang N; Zhang Y; Xu W; Chen Y; Fei X; Wang J Mol Carcinog; 2022 Nov; 61(11):975-988. PubMed ID: 35924788 [TBL] [Abstract][Full Text] [Related]
20. Effect of Curcumin in Comparison with Trichostatin A on the Reactivation of Estrogen Receptor Alpha gene Expression, Cell Growth Inhibition and Apoptosis Induction in Hepatocellular Carcinoma Hepa 1-6 Cell lLine. Sanaei M; Kavoosi F; Arabloo M Asian Pac J Cancer Prev; 2020 Apr; 21(4):1045-1050. PubMed ID: 32334468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]